Arrow Greentech Limited — Annual Report FY2026
Quality Scores
AI Summary
Incorporated in 1982, Arrow Greentech is a specialized technology-driven company and India's largest manufacturer of water-soluble films (PVA/PVOH). The company operates at the intersection of green packaging and high-tech security products, notably diversifying into pharmaceutical mouth-dissolving strips. Following a period of extreme volatility and losses between FY19 and FY22, the business has staged a dramatic recovery with FY25-26 revenue and profits reaching record highs. It maintains a nearly debt-free balance sheet and high return ratios, positioning itself as a niche player in the…
Key Changes
The company has undergone a significant transformation from a niche manufacturer of water-soluble films into a high-tech IP-driven entity specializing in PVP/PVOH films and security products. The evolution includes a pivot towards pharmaceutical and nutraceutical applications (Avery Pharma), moving up the value chain from industrial packaging to specialized oral delivery systems. Geographically, it has leveraged its UK subsidiary to protect its global patent portfolio, showcasing a move from a domestic vendor to an international technology provider. The timeline reveals a transition from a loss-making period in 2019-2022, caused by R&D and market development costs, to a highly profitable phase in 2024-2026. This trajectory reflects a 'Strong Evolution' as the company successfully…
Management Commentary
Management has successfully steered the company through a difficult period of product transition and patent cycles. Leadership focuses heavily on R&D and intellectual property, evidenced by the tracking of patent grants and FSSAI approvals as key performance indicators. Transparency has improved with regular investor presentations and con-calls since 2023. However, the decrease in promoter holding from 70.35% (FY22) to 64.83% (FY26) is a monitorable, even if the absolute holding remains high. The vision is clearly anchored in high-margin, technology-intensive green solutions rather than low-margin mass packaging.
Financial Highlights
The 10-year financial performance is a tale of two halves: stagnant-to-negative growth during a long cycle of losses (FY18-FY22) followed by a sharp 51% CAGR profit explosion over the last 5 years. Sales grew from ₹49 Cr in FY15 to ₹201 Cr in FY26, though peaking at ₹243 Cr in FY25, indicating some quarterly cyclicality. Operating margins are exceptionally high, often exceeding 30%, largely driven by patent income and high-value niche products. Net profit reached ₹47 Cr in FY26, recovering from a ₹17 Cr loss in FY19. Return on Equity (ROE) has stabilized at a robust 22.4%, marking a successful turnaround from previous capital erosion.
Major Opportunities
- Almost debt-free balance sheet
- Superior ROCE of 30%+
- Patented technology in water-soluble films
Major Risks
- Inconsistent revenue history with deep cyclicality
- Severe promoter holding reduction (-3.7% in 3 years)
- High Working Capital days (239 days)
Unlock the full report
Full 20+ sections, charts, AI chat with the report, and PDF export are available with Premium.